Stocks higher after retail sales improve

A strong gain in retail spending sent stocks upward Monday. A positive earnings report from Citigroup was responsible for a broad rise in bank stocks.

Richard Drew/AP
Specialist Jason Hardzewicz, left, and trader George Ettinger work on the floor of the New York Stock Exchange Monday. Stocks opened higher Monday on Wall Street after a strong report on retail sales.

Stocks rose on Monday after a strong gain in retail spending suggested that consumers could be getting more confident about the U.S. economy. Bank stocks rose broadly after Citigroup delivered a strong earnings report.

The Dow rose 95.38 points to close at 13,424.23, its biggest gain since September 13.

The Standard & Poor's 500 index was up 11.54 points at 1,440.13 and the Nasdaq composite index rose 20.07 points to 3,064.18.

Companies that rely on consumer spending, like Lowe's, TJX Cos. and Yum Brands, rose after the government reported that retail sales rose 1.1 percent in the U.S. last month. The Commerce Department also revised August growth up to 1.2 percent, marking the two largest gains since October 2010.

Sales rose in most major categories. Electronics and appliances jumped 4.5 percent with help from the new iPhone. Sales at auto dealers increased 1.3 percent. Building materials and garden supplies, furniture and clothing sales all gained, too.

"The retail sales numbers tell us that the economy in general, and consumer spending in particular, probably did better than most expected in the third quarter," said Hugh Johnson, chairman and chief investment officer of Johnson Illington Advisors.

Citigroup rose $1.91, or 5.5 percent, to $36.66 after beating beat Wall Street earnings estimates.

Most other financial stocks followed Citi higher. Bank of America rose 3.5 percent, and JPMorgan Chase rose 1.8 percent. However, Wells Fargo continued to struggle after reporting a record profit on Friday. Analysts warned it might have trouble making money on interest payments for loans. Its stock fell 1 percent on Monday, after dropping on Friday, too.

Economic figures from China helped support markets in Europe at the start of a week that could offer greater clarity on the economic fates of Greece and Spain.

China's inflation rate fell to 1.9 percent in September from 2 percent the month before, reinforcing investor hopes for more stimulus in the world's second-largest economy.

Good news for two major drugmakers boosted pharmaceutical stocks and pushed the whole health sector to the biggest gains among 10 industry groups in the S&P 500.

Eli Lilly said a potential stomach cancer treatment met goals for improved patient survival. It hasn't yet submitted the drug, ramucirumab, for government approval.

And Abbott Laboratories said an experimental drug regimen cured 99 percent of patients with hepatitis C. Patients in the trial had genotype 1 hepatitis C, the most common type in the Western world, and the hardest to treat.

Eli Lilly rose $2.08, or 4 percent, to $52.53. Abbott rose $2.77, also 4 percent, to $72.05. Other drugmakers also rose. Pfizer and Merck rose more than 1 percent and Bristol-Myers Squibb rose 2.5 percent.

Telecommunications stocks were the only declining industry among the 10 in the S&P 500.

Travel deals website operator Travelzoo Inc. fell again after warning on Friday that its poorly-performing hotel search business will hurt third-quarter results. On Monday, its stock fell 85 cents, or 4.2 percent, to $19.17.

Home health care provider Amedisys Inc. fell $1.25, or 9.4 percent, to $12.08 after saying revenue from health insurer Humana Inc. will shrink.

Investors sold government bonds and drove yields slightly higher. The yield on the 10-year U.S. Treasury note rose to 1.67 percent from 1.66 percent Friday.

The price of crude oil fell a penny to finish at $91.85 on the New York Mercantile Exchange.

You've read  of  free articles. Subscribe to continue.
Real news can be honest, hopeful, credible, constructive.
What is the Monitor difference? Tackling the tough headlines – with humanity. Listening to sources – with respect. Seeing the story that others are missing by reporting what so often gets overlooked: the values that connect us. That’s Monitor reporting – news that changes how you see the world.

Dear Reader,

About a year ago, I happened upon this statement about the Monitor in the Harvard Business Review – under the charming heading of “do things that don’t interest you”:

“Many things that end up” being meaningful, writes social scientist Joseph Grenny, “have come from conference workshops, articles, or online videos that began as a chore and ended with an insight. My work in Kenya, for example, was heavily influenced by a Christian Science Monitor article I had forced myself to read 10 years earlier. Sometimes, we call things ‘boring’ simply because they lie outside the box we are currently in.”

If you were to come up with a punchline to a joke about the Monitor, that would probably be it. We’re seen as being global, fair, insightful, and perhaps a bit too earnest. We’re the bran muffin of journalism.

But you know what? We change lives. And I’m going to argue that we change lives precisely because we force open that too-small box that most human beings think they live in.

The Monitor is a peculiar little publication that’s hard for the world to figure out. We’re run by a church, but we’re not only for church members and we’re not about converting people. We’re known as being fair even as the world becomes as polarized as at any time since the newspaper’s founding in 1908.

We have a mission beyond circulation, we want to bridge divides. We’re about kicking down the door of thought everywhere and saying, “You are bigger and more capable than you realize. And we can prove it.”

If you’re looking for bran muffin journalism, you can subscribe to the Monitor for $15. You’ll get the Monitor Weekly magazine, the Monitor Daily email, and unlimited access to

QR Code to Stocks higher after retail sales improve
Read this article in
QR Code to Subscription page
Start your subscription today